These insights reveal a novel aspect of FTO’s role in cancer biology, indicating that its impact on endometrial cancer is not merely a consequence of its association with body weight but involves distinct mechanisms that warrant further investigation (82). This evidence concerns the gene FTO and endometrial cancer.